Review
Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment
Affiliations
- PMID: 15742464
Item in Clipboard
Review
Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment
J Rheumatol Suppl.
2005 Mar.
Abstract
This review examines the differences in the incidence, spectrum, and mechanisms of activation of opportunistic infections, such as Mycobacterium tuberculosis, in patients with rheumatic diseases treated with the soluble TNF p75 receptor etanercept compared to the 2 anti-TNF-alpha monoclonal antibodies, infliximab and adalimumab.
Similar articles
-
The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.Int J Rheum Dis. 2009 Jul;12(2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x. Int J Rheum Dis. 2009. PMID: 20374328
-
Serious infections associated with anticytokine therapies in the rheumatic diseases.J Intensive Care Med. 2004 Nov-Dec;19(6):320-34. doi: 10.1177/0885066604267854. J Intensive Care Med. 2004. PMID: 15523118 Review.
-
Why does tumor necrosis factor targeted therapy reactivate tuberculosis?J Rheumatol Suppl. 2005 Mar;74:35-9. J Rheumatol Suppl. 2005. PMID: 15742463 Review.
-
Problems encountered during anti-tumour necrosis factor therapy.Best Pract Res Clin Rheumatol. 2006 Aug;20(4):757-90. doi: 10.1016/j.berh.2006.06.002. Best Pract Res Clin Rheumatol. 2006. PMID: 16979537 Review.
-
Safety of biologic therapies--an update.J Rheumatol Suppl. 2005 Mar;74:8-12. J Rheumatol Suppl. 2005. PMID: 15742458 Review.
Cited by
-
Dysregulation of Leukocyte Trafficking in Type 2 Diabetes: Mechanisms and Potential Therapeutic Avenues.Front Cell Dev Biol. 2021 Feb 22;9:624184. doi: 10.3389/fcell.2021.624184. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33692997 Free PMC article. Review.
-
Role of TNFalpha in pulmonary pathophysiology.Respir Res. 2006 Oct 11;7(1):125. doi: 10.1186/1465-9921-7-125. Respir Res. 2006. PMID: 17034639 Free PMC article. Review.
-
Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed.J Clin Invest. 2009 May;119(5):1079-82. doi: 10.1172/jci39143. J Clin Invest. 2009. PMID: 19422095 Free PMC article.
-
The safety of etanercept for the treatment of plaque psoriasis.Ther Clin Risk Manag. 2007 Jun;3(2):245-58. doi: 10.2147/tcrm.2007.3.2.245. Ther Clin Risk Manag. 2007. PMID: 18360633 Free PMC article.
-
Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines.Virology. 2007 Dec 20;369(2):288-98. doi: 10.1016/j.virol.2007.07.030. Epub 2007 Sep 5. Virology. 2007. PMID: 17804032 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
